M Christ-Crain1,2, W K Fenske3,4. 1. Department of Endocrinology, Diabetology and Metabolism, University Hospital of Basel, University of Basel, Petersgraben 4, 4031, Basel, Switzerland. mirjam.christ-crain@unibas.ch. 2. Medical Department III-Endocrinology, Nephrology, Rheumatology, University of Leipzig Medical Center, University Hospital Leipzig, Leipzig, Germany. mirjam.christ-crain@unibas.ch. 3. Department of Endocrinology, Diabetology and Metabolism, University Hospital of Basel, University of Basel, Petersgraben 4, 4031, Basel, Switzerland. WiebkeKristin.Fenske@medizin.uni-leipzig.de. 4. Medical Department III-Endocrinology, Nephrology, Rheumatology, University of Leipzig Medical Center, University Hospital Leipzig, Leipzig, Germany. WiebkeKristin.Fenske@medizin.uni-leipzig.de.
Abstract
COPEPTIN: Copeptin is secreted in equimolar amount to Arginine Vasopressin (AVP) but can easily be measured with a sandwich immunoassay. Both peptides, copeptin and AVP, show a high correlation. Accordingly, copeptin mirrors the amount of AVP in the circulation and its measurement provides an attractive marker in the differential diagnosis of diabetes insipidus. THE POLYURIA POLYDIPSIA SYNDROME: Diabetes insipidus-either central or nephrogenic-has to be differentiated from primary polydipsia. Differentiation is crucial since wrong treatment can have deleterious consequences. Since many decades, the "gold standard" for differential diagnosis has been the classical water deprivation test, which has several limitations leading to an overall limited diagnostic accuracy. In addition, the test has a long duration of 17 hours and is cumbersome for patients. Clinical signs and symptoms as well as MRI characteristics overlap between patients with diabetes insipidus and primary polydipsia. Direct measurement of AVP upon osmotic stimulation was first shown to overcome these limitations, but failed to enter clinical practice mainly due to technical limitations of the AVP assay. COPEPTIN AS DIAGNOSTIC TOOL IN THE POLYURIA POLYDIPSIA SYNDROME: We have recently shown that copeptin, without prior water deprivation, identifies patients with nephrogenic diabetes insipidus. On the other hand, for the more difficult differentiation between central diabetes insipidus and primary polydipsia, a copeptin level of 4.9 pmol/L stimulated with hypertonic saline infusion differentiates between these two entities with a high diagnostic accuracy, and is superior to the water deprivation test. It is important to note that close sodium monitoring during the hypertonic saline test is a prerequisite. CONCLUSION: Therefore, we propose that copeptin upon hypertonic saline infusion should become the new standard test in the differential diagnosis of diabetes insipidus.
COPEPTIN: Copeptin is secreted in equimolar amount to Arginine Vasopressin (AVP) but can easily be measured with a sandwich immunoassay. Both peptides, copeptin and AVP, show a high correlation. Accordingly, copeptin mirrors the amount of AVP in the circulation and its measurement provides an attractive marker in the differential diagnosis of diabetes insipidus. THE POLYURIA POLYDIPSIA SYNDROME: Diabetes insipidus-either central or nephrogenic-has to be differentiated from primary polydipsia. Differentiation is crucial since wrong treatment can have deleterious consequences. Since many decades, the "gold standard" for differential diagnosis has been the classical water deprivation test, which has several limitations leading to an overall limited diagnostic accuracy. In addition, the test has a long duration of 17 hours and is cumbersome for patients. Clinical signs and symptoms as well as MRI characteristics overlap between patients with diabetes insipidus and primary polydipsia. Direct measurement of AVP upon osmotic stimulation was first shown to overcome these limitations, but failed to enter clinical practice mainly due to technical limitations of the AVP assay. COPEPTIN AS DIAGNOSTIC TOOL IN THE POLYURIA POLYDIPSIA SYNDROME: We have recently shown that copeptin, without prior water deprivation, identifies patients with nephrogenic diabetes insipidus. On the other hand, for the more difficult differentiation between central diabetes insipidus and primary polydipsia, a copeptin level of 4.9 pmol/L stimulated with hypertonic saline infusion differentiates between these two entities with a high diagnostic accuracy, and is superior to the water deprivation test. It is important to note that close sodium monitoring during the hypertonic saline test is a prerequisite. CONCLUSION: Therefore, we propose that copeptin upon hypertonic saline infusion should become the new standard test in the differential diagnosis of diabetes insipidus.
Authors: I Fujisawa; K Nishimura; R Asato; K Togashi; K Itoh; S Noma; Y Kawamura; T Sago; S Minami; Y Nakano Journal: J Comput Assist Tomogr Date: 1987 Mar-Apr Impact factor: 1.826
Authors: Katharina Timper; Wiebke Fenske; Felix Kühn; Nica Frech; Birsen Arici; Jonas Rutishauser; Peter Kopp; Bruno Allolio; Christoph Stettler; Beat Müller; Mira Katan; Mirjam Christ-Crain Journal: J Clin Endocrinol Metab Date: 2015-03-13 Impact factor: 5.958
Authors: E Ferrante; A Cremaschi; A L Serban; R Indirli; G Grassi; M Locatelli; M Arosio; G Mantovani Journal: J Endocrinol Invest Date: 2021-02-20 Impact factor: 4.256